<p>Rajan George of Paladin Biosciences, a division of Paladin Labs Inc. in Canada will produce a vaccine with multiple malaria antigens to target dendritic cell receptors and without the need for an adjuvant, in an effort to induce both antibody and cell-mediated immune responses to the malaria parasite at various stages of the infection.</p>


Rajan George of Paladin Biosciences, a division of Paladin Labs Inc. in Canada will produce a vaccine with multiple malaria antigens to target dendritic cell receptors and without the need for an adjuvant, in an effort to induce both antibody and cell-mediated immune responses to the malaria parasite at various stages of the infection.